documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
47 rows where docket_id = "FDA-2005-D-0211" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, last_modified, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 2
agency_id 1
- FDA 47
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2005-D-0211-0050 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | FDA | Notice | NAD-Notice of Availability of Data | 2007-10-29T04:00:00Z | 2007 | 10 | 2007-10-26T04:00:00Z | 2008-04-11T23:46:52Z | 0 | 0 | 0900006480441500 | ||
| FDA-2005-D-0211-0049 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Considerations for Plasmid DNA Vaccines for Infectious Disease Indications | Supporting & Related Material | Guidance | 2007-10-29T04:00:00Z | 2007 | 10 | 2020-05-14T14:43:32Z | 0 | 0 | 09000064804414ff | |||
| FDA-2005-D-0211-0026 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414e6 | |||
| FDA-2005-D-0211-0013 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414d3 | |||
| FDA-2005-D-0211-0012 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414d2 | |||
| FDA-2005-D-0211-0009 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:52Z | 0 | 0 | 09000064804414cf | |||
| FDA-2005-D-0211-0034 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:52Z | 0 | 0 | 09000064804414ee | |||
| FDA-2005-D-0211-0045 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:52Z | 0 | 0 | 09000064804414fa | |||
| FDA-2005-D-0211-0019 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:52Z | 0 | 0 | 09000064804414da | |||
| FDA-2005-D-0211-0044 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414f9 | |||
| FDA-2005-D-0211-0032 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:52Z | 0 | 0 | 09000064804414ec | |||
| FDA-2005-D-0211-0046 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:52Z | 0 | 0 | 09000064804414fb | |||
| FDA-2005-D-0211-0025 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:52Z | 0 | 0 | 09000064804414e4 | |||
| FDA-2005-D-0211-0038 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414f2 | |||
| FDA-2005-D-0211-0042 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:54Z | 0 | 0 | 09000064804414f7 | |||
| FDA-2005-D-0211-0008 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414ce | |||
| FDA-2005-D-0211-0006 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414cc | |||
| FDA-2005-D-0211-0015 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414d5 | |||
| FDA-2005-D-0211-0022 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414e1 | |||
| FDA-2005-D-0211-0028 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414e8 | |||
| FDA-2005-D-0211-0047 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:54Z | 0 | 0 | 09000064804414fd | |||
| FDA-2005-D-0211-0021 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:52Z | 0 | 0 | 09000064804414dd | |||
| FDA-2005-D-0211-0017 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414d8 | |||
| FDA-2005-D-0211-0014 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:54Z | 0 | 0 | 09000064804414d4 | |||
| FDA-2005-D-0211-0011 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414d1 | |||
| FDA-2005-D-0211-0024 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414e3 | |||
| FDA-2005-D-0211-0043 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414f8 | |||
| FDA-2005-D-0211-0029 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:54Z | 0 | 0 | 09000064804414e9 | |||
| FDA-2005-D-0211-0037 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414f1 | |||
| FDA-2005-D-0211-0048 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:54Z | 0 | 0 | 09000064804414fe | |||
| FDA-2005-D-0211-0036 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414f0 | |||
| FDA-2005-D-0211-0039 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:54Z | 0 | 0 | 09000064804414f3 | |||
| FDA-2005-D-0211-0031 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414eb | |||
| FDA-2005-D-0211-0010 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414d0 | |||
| FDA-2005-D-0211-0023 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:54Z | 0 | 0 | 09000064804414e2 | |||
| FDA-2005-D-0211-0033 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:54Z | 0 | 0 | 09000064804414ed | |||
| FDA-2005-D-0211-0020 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414db | |||
| FDA-2005-D-0211-0007 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414cd | |||
| FDA-2005-D-0211-0030 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:52Z | 0 | 0 | 09000064804414ea | |||
| FDA-2005-D-0211-0018 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:54Z | 0 | 0 | 09000064804414d9 | |||
| FDA-2005-D-0211-0041 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:54Z | 0 | 0 | 09000064804414f5 | |||
| FDA-2005-D-0211-0040 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414f4 | |||
| FDA-2005-D-0211-0016 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414d6 | |||
| FDA-2005-D-0211-0035 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414ef | |||
| FDA-2005-D-0211-0027 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2007-10-26T04:00:00Z | 2007 | 10 | 2008-04-11T23:46:53Z | 0 | 0 | 09000064804414e7 | |||
| FDA-2005-D-0211-0002 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | GUIDANCE | Supporting & Related Material | GDL-Guidance | 2005-03-01T05:00:00Z | 2005 | 3 | 2008-04-11T23:46:52Z | 0 | 0 | 090000648044146e | |||
| FDA-2005-D-0211-0001 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | FDA | Notice | NAD-Notice of Availability of Data | 2005-03-01T05:00:00Z | 2005 | 3 | 2005-02-18T05:00:00Z | 2005-05-20T03:59:59Z | 2008-04-11T23:46:52Z | 0 | 0 | 0900006480441299 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;